SLNO
Soleno Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$53.01
+0.00%Margins
Gross margin
98.6%
EBITDA margin
36.0%
EBIT margin
30.8%
Net margin
33.7%
FCF margin
37.1%
19.4%
Return on equity
15.8%
Return on assets
17.5%
Return on invested capital
0.49x
Asset turnover
$105.7M
Cash from operations
$4.90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026